About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
This model of the use of chimeric antigen receptor (CAR)-T cell therapy in the treatment of solid tumours is described in the article:'Dual-Target CAR-Ts with On- and Off-Tumour Activity May Override. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.
Manifest
{
"io": {
"inputs": [
{
"name": "initial_car_t_cells",
"label": "Initial Car T Cells",
"units": "native source value",
"default": 400000000,
"maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.initial_car_t_cells",
"description": "Initial Car T Cells. Sets the initial value of bundled SBML species `CAR_T_cells`."
},
{
"name": "initial_tumour_cells",
"label": "Initial Tumour Cells",
"units": "native source value",
"default": 6700000000,
"maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.initial_tumour_cells",
"description": "Initial Tumour Cells. Sets the initial value of bundled SBML species `Tumour_cells`."
},
{
"name": "tumour_death_rate",
"label": "Tumour Death Rate",
"units": "unit_3",
"default": 2.5e-10,
"maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.tumour_death_rate",
"description": "Tumour Death Rate. Sets bundled SBML parameter `alpha_2`."
}
],
"outputs": [
{
"name": "car_t_cells",
"maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.car_t_cells"
},
{
"name": "tumour_cells",
"maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.tumour_cells"
},
{
"name": "state",
"maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.state"
},
{
"name": "summary",
"maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.summary"
},
{
"name": "species_labels",
"maps_to": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.species_labels"
}
]
},
"title": "Leon-Triana2021 - Competition between tumour cells and single-target CAR T-cells Lab",
"models": [
{
"path": "models/core",
"alias": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model"
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model_state"
],
"from": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.state"
},
{
"to": [
"visualisation.immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model_summary"
],
"from": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.summary"
},
{
"to": [
"visualisation.immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model_species_labels"
],
"from": "immunology_sbml_leon_triana2021_competition_between_tumour_cells_biomd0000001013_model.species_labels"
}
],
"package": "leon-triana2021-competition-between-tumour-cells-and-si-7abe2ca7",
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"version": "1.0.0",
"description": "This model of the use of chimeric antigen receptor (CAR)-T cell therapy in the treatment of solid tumours is described in the article:'Dual-Target CAR-Ts with On- and Off-Tumour Activity May Override. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.",
"schema_version": "2.0"
}Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packageleon-triana2021-competition-between-tumour-cells-and-si-7abe2ca7
Created2026-05-15
Updated2026-06-13
immunologysbmlbiomodels_ebifaithfulcuratedvisualisationother